A-to-I RNA editing and cancer: From pathology to basic science

RNA Biology

Volumn 5, Issue 3, 2008, Pages

  Gallo, Angela ^a,c   Galardi, Silvia ^b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c OPBG   (Italy)

Author keywords

ADARs; Astrocytomas; Cancer; GBM; Inosine; MicroRNA; Post transcriptional regulation; RNA binding protein; RNA editing

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; DOUBLE STRANDED RNA; INOSINE; MESSENGER RNA; MICRORNA; DSRNA ADENOSINE DEAMINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ASTROCYTOMA; CHILDHOOD CANCER; ENZYME ACTIVITY; ENZYME SUBSTRATE; GLIOBLASTOMA; HUMAN; NEOPLASM; NONHUMAN; REVIEW; RNA EDITING; RNA PROCESSING; RNA SEQUENCE; RNA STRUCTURE; TUMOR GROWTH; ANIMAL; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY;

EUKARYOTA; MAMMALIA;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; HUMANS; INOSINE; NEOPLASMS; RNA EDITING; SUBSTRATE SPECIFICITY;

EID: 54349084037     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.5.3.6739     Document Type: Review

References (56)

1. Kampa D, Cheng J, Kapranov P, Yamanaka M, Brubaker S, Cawley S, Drenkow J, Piccolboni A, Bekiranov S, Helt G, Tammana H, Gingeras TR. Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome research 2004; 14:331-42.
2. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003; 302:2141-4.
3. Bass BL. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 2002; 71:817-46.
4. Gott JM, Emeson RB. Functions and mechanisms of RNA editing. Annu Rev Genet 2000; 34:499-531.
5. Macbeth MR, Schubert HL, Vandemark AP, Lingam AT, Hill CP, Bass BL. Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science 2005; 309:1534-9.
6. Rebagliati MR, Melton DA. Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity. Cell 1987; 48:599-605.
7. Bass BL, Weintraub H. A developmentally regulated activity that unwinds RNA duplexes. Cell 1987; 48:607-13.
8. Keegan LP, Gallo A, O'Connell MA. The many roles of an RNA editor. Nature reviews 2001; 2:869-78.
9. Paul MS, Bass BL. Inosine exists in mRNA at tissue-specific levels and is most abundant in brain mRNA. The EMBO journal 1998; 17:1120-7.
10. Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D, Olshansky M, Rechavi G, Jantsch MF. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nature biotechnology 2004; 22:1001-5.
11. Levanon K, Eisenberg E, Rechavi G, Levanon EY. Letter from the editor: Adenosine-to-inosine RNA editing in Alu repeats in the human genome. EMBO reports 2005; 6:831-5.
12. Morse DP, Bass BL. Long RNA hairpins that contain inosine are present in Caenorhabditis elegans poly(A)+ RNA. Proc Natl Acad Sci USA 1999; 96:6048-53.
13. Athanasiadis A, Rich A, Maas S. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol 2004; 2:391.
14. Kim DD, Kim TT, Walsh T, Kobayashi Y, Matise TC, Buyske S, Gabriel A. Widespread RNA editing of embedded alu elements in the human transcriptome. Genome research 2004; 14:1719-25.
15. Eisenberg E, Nemzer S, Kinar Y, Sorek R, Rechavi G, Levanon EY. Is abundant A-to-I RNA editing primate-specific? Trends Genet 2005; 21:77-81.
16. Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N, Feldmeyer D, Sprengel R, Seeburg PH. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000; 406:78-81.
17. Wang Q, Khillan J, Gadue P, Nishikura K. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 2000; 290:1765-8.
18. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997; 387:303-8.
19. Lai F, Chen CX, Lee VM, Nishikura K. Dramatic increase of the RNA editing for glutamate receptor subunits during terminal differentiation of clonal human neurons. J Neurochem 1997; 69:43-52.
20. Cenci C, Barzotti R, Galeano F, Corbelli S, Rota R, Massimi L, Di Rocco C, O'Connell MA, Gallo A. Downregulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. The Journal of biological chemistry 2008; 283:7251-60.
21. Lehmann KA, Bass BL. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 2000; 39:12875-84.
22. Polson AG, Bass BL. Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase. The EMBO journal 1994; 13:5701-11.
23. Wong SK, Sato S, Lazinski DW. Substrate recognition by ADAR1 and ADAR2. RNA (New York, NY 2001; 7:846-58.
24. Laurencikiene J, Kallman AM, Fong N, Bentley DL, Ohman M. RNA editing and alternative splicing: the importance of co-transcriptional coordination. EMBO reports 2006; 7:303-7.
25. Gallo A, Keegan LP, Ring GM, O'Connell MA. An ADAR that edits transcripts encoding ion channel subunits functions as a dimer. The EMBO journal 2003; 22:3421-30.
26. Poulsen H, Jorgensen R, Heding A, Nielsen FC, Bonven B, Egebjerg J. Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain. RNA 2006; 12:1350-60.
27. Valente L, Nishikura K. RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions. The Journal of biological chemistry 2007; 282:16054-61.
28. Nie Y, Ding L, Kao PN, Braun R, Yang JH. ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing. Molecular and cellular biology 2005; 25:6956-63.
29. Maas S, Kawahara Y, Tamburro KM, Nishikura K. A-to-I RNA Editing and Human Disease. RNA Biol 2006; 3.
30. Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M, Hirschberg A, Krupsky M, Ben-Dov I, Cazacu S, Mikkelsen T, Brodie C, Eisenberg E, Rechavi G. Altered adenosine-to-inosine RNA editing in human cancer. Genome research 2007; 17:1586-95.
31. Maas S, Patt S, Schrey M, Rich A. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci USA 2001; 98:14687-92.
32. Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada N, Hagimura N, Okado H, Miwa A, Kurihara H, Nakazato Y, Tamura M, Sasaki T, Ozawa S. Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 2002; 8:971-8.
33. Beghini A, Ripamonti CB, Peterlongo P, Roversi G, Cairoli R, Morra E, Larizza L. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum Mol Genet 2000; 9:2297-304.
34. 2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci 2007; 27:7987-8001.
35. Rickert CH, Paulus W. Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst 2001; 17:503-11.
36. Cohen KJ, Broniscer A, Glod J. Pediatric glial tumors. Curr Treat Options Oncol 2001; 2:529-36.
37. Riedmann EM, Schopoff S, Hartner JC, Jantsch MF. Specificity of ADAR-mediated RNA editing in newly identified targets. RNA 2008; 14:1110-8.
38. Nishimoto Y, Yamashita T, Hideyama T, Tsuji S, Suzuki N, Kwak S. Determination of editors at the novel A-to-I editing positions. Neuroscience research 2008; 61:201-6.
39. Levanon EY, Eisenberg E. Algorithmic approaches for identification of RNA editing sites. Brief Funct Genomic Proteomic 2006; 5:43-5.
40. Hoopengardner B, Bhalla T, Staber C, Reenan R. Nervous system targets of RNA editing identified by comparative genomics. Science 2003; 301:832-6.
41. Morse DP, Bass BL. Detection of inosine in messenger RNA by inosine-specific cleavage. Biochemistry 1997; 36:8429-34.
42. Ohlson J, Enstero M, Sjoberg BM, Ohman M. A method to find tissue-specific novel sites of selective adenosine deamination. Nucleic acids research 2005; 33:167.
43. Luciano DJ, Mirsky H, Vendetti NJ, Maas S. RNA editing of a miRNA precursor. RNA 2004; 10:1174-7.
44. Nishikura K. Editor meets silencer: crosstalk between RNA editing and RNA interference. Nat Rev Mol Cell Biol 2006; 7:919-31.
45. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14:778-809.
46. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008; 133:217-22.
47. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115:199-208.
48. Blow MJ, Grocock RJ, van Dongen S, Enright AJ, Dicks E, Futreal PA, Wooster R, Stratton MR. RNA editing of human microRNAs. Genome Biol 2006; 7:27.
49. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grasser FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T. Identification of microRNAs of the herpesvirus family. Nature methods 2005; 2:269-76.
50. Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, Nishikura K. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 2007; 315:1137-40.
51. Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura K. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO reports 2007; 8:763-9.
52. Yang W, Chendrimada TP, Wang Q, Higuchi M, Seeburg PH, Shiekhattar R, Nishikura K. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol 2006; 13:13-21.
53. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD. Expression profiling identifies microRNA signature in pancreatic cancer. International journal of cancer 2007; 120:1046-54.
54. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303:83-6.
55. Wong EL, Damania B. Linking KSHV to human cancer. Current oncology reports 2005; 7:349-56.
56. Gandy SZ, Linnstaedt SD, Muralidhar S, Cashman KA, Rosenthal LJ, Casey JL. RNA editing of the human herpesvirus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication. Journal of virology 2007; 81:13544-51.